<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Neuroinflammation plays a critical role in the pathogenesis of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Triflusal, a selective cyclooxygenase-2, and its active metabolite 3-hydroxy-4-trifluoromethylbenzoic acid may inhibit <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0001845'>inflammation</z:mp> after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>An in vivo model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was used to investigate the effects of triflusal and aspirin treatment on <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, and <z:mp ids='MP_0001845'>inflammation</z:mp> after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in the rat </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Male Wistar rats were subjected to a permanent right-sided middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Rats received oral administration of either triflusal or aspirin </plain></SENT>
<SENT sid="5" pm="."><plain>After 3 days after surgery, immunostaining was used to detect neuroinflammatory cells and molecules, and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were measured </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Both triflusal and aspirin at a dose of 30 mg/kg but not 10 mg/kg significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume compared with vehicle treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulted in increased astrocyte and heat shock protein-27 (Hsp27) immunostaining in the ipsilateral cortex </plain></SENT>
<SENT sid="8" pm="."><plain>Triflusal (30 mg/kg) or aspirin treatment (30 mg/kg) did not reduce the levels of GFAP or Hsp27 immunostaining </plain></SENT>
<SENT sid="9" pm="."><plain>Triflusal (30 mg/kg) also significantly decreased the protein levels of IL-Ibeta but not nuclear factor kappa B or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha in the cortex ipsilateral to the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The results suggest that triflusal and aspirin appear to be equally neuroprotective against middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>-induced <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, strong rationale exists to continue the neuroprotective examination of triflusal in brain injury </plain></SENT>
</text></document>